Lactobacillus upregulates the expression of glucagon‐like peptide‐1 (GLP‐1) and interleukin (IL)‐10 in patients with obesity or T2DM and suppresses lipid accumulation in adipocytes (Kim et al. 2019; Alard et al. 2021). Here, GLP1R is linked to type 2 diabetes mellitus.